A phase II, randomised, double-blind study to compare the safety and efficacy of one treatment cycle of Clostridium Botulinum type A toxin (50 units) when reconstituted from either a 125 unit or a 500 unit presentation for the treatment of glabellar lines

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.